CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Moss Genomics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Moss Genomics Inc
Suite 907, 1030 West Georgia Street
VANCOUVER, BC  V6E 2Y3  Canada Ticker: MOSSMOSS
Business Summary
Moss Genomics Inc. is a Canada-based biotechnology company utilizing artificial intelligence, genomic, microbiome, and a diverse array of health data to develop health solutions. The Company offers personalized health, anti-aging and wellness offerings. The Company’s products include Gut Health Complete, Gut + Mental Health Complete and Personalized Probiotic Products. Its services include the provision of a saliva and fecal home collection kit, genomic and gut microbiome sequencing and analysis and provision of health reports containing personalized and actionable wellness recommendations based on individual gut and deoxyribonucleic acid (DNA) sequencing results. It consists of three components, which include consumer genetic testing; personalized health, anti-aging and wellness offerings, and improving pharma and biotech drug development using the Company’s Multi-Omics Database. The Company operates in San Diego, California. Its wholly owned subsidiary is Moss Genomics Holdings Inc.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20246/30/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
8099 Health and allied services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Corporate Secretary MichelleLee 29 5/30/2024 1/11/2021
Chief Executive Officer, Interim Chief Financial Officer, Director KarlCahill 50 5/30/2024 1/11/2021
Director Min SeobLee 57 4/29/2022 4/29/2022
Independent Director Mark T.Tommasi 51 4/29/2022 4/29/2022

Business Names
Business Name
MOSS
Moss Genomics Holdings Inc.
Moss Genomics Inc

General Information
Outstanding Shares: 44,827,000 (As of 6/30/2024)
Stock Exchange: CNQ


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024